Cesca Therapeutics

Cesca Therapeutics Inc. is a clinical-stage biotechnology company. The company is committed to the development and manufacturing of automated blood and bone marrow processing systems for the isolation, processing, and preservation of cell and tissue therapy products. The company's device division, ThermoGenesis Corp, provides comprehensive solutions for automated clinical biobanking, point-of-care applications, and immunotherapy automation. Cesca’s clinical development division is leveraging its proprietary AutoXpress technology platform to develop autologous stem cell-based therapies aimed at addressing significant unmet needs in the fields of immuno-oncology, vascular, cardiology, and orthopedics.